Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity

被引：50

作者：

Chetan, Bhadaliya ^{[1
]}

Bunha, Mahesh ^{[1
]}

Jagrat, Monika ^{[1
]}

Sinha, Barij Nayan ^{[1
]}

Saiko, Philipp ^{[1
]}

Graser, Geraldine ^{[2
]}

Szekeres, Thomas ^{[2
]}

Raman, Ganapathy ^{[3
]}

Rajendran, Praveen ^{[3
]}

Moorthy, Dhatchana ^{[3
]}

Basu, Arijit ^{[1
]}

Jayaprakash, Venkatesan ^{[1
]}

机构：

[1] Birla Inst Technol, Dept Pharmaceut Sci, Ranchi 835215, Jharkhand, India

[2] Gen Hosp Vienna Med Univ Vienna, Dept Med & Chem Lab Diagnost, A-1090 Vienna, Austria

[3] Orchid Res Labs Ltd, Madras 600119, Tamil Nadu, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 13期

关键词：

Histone deacetylase inhibitors; Piperazine linker; Hydroxamates; RR pharmacophore; ASSAY; AGENTS; PROLIFERATION;

D O I：

10.1016/j.bmcl.2010.05.020

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Six compounds were synthesized with piperazine in linker region and hydroxamate as Zinc Binding Group ( ZBG). They were screened against three cancer cell-lines (NCIH460; HCT116; U251). Compounds 5c and 5f with GI(50) value of 9.33 +/- 1.3 mu M and 12.03 +/- 4 mu M, respectively, were tested for their inhibitory potential on hHDAC8. Compound 5c had IC(50) of 33.67 mu M. Compounds were also screened for their anticancer activity against HL60 human promyelocytic leukemia cell line due to the presence of pharmacophoric features of RR inhibitors in them. Compound 5c had IC(50) of 0.6 mu M at 48 h. (c) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3906 / 3910

页数：5

共 50 条

[31] Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen - A new hybrid design paradigm
Palermo, Anthony F.
Diennet, Marine
El Ezzy, Mohamed
Williams, Benjamin M.
Cotnoir-White, David
Mader, Sylvie
Gleason, James L.
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (15) : 4428 - 4440
[32] The novel histone deacetylase inhibitor OSU-HDAC42 has class I and II histone deacetylase (HDAC) inhibitory activity and represents a novel therapy for chronic lymphocytic leukemia.
West, Derek A.
Lucas, David M.
Davis, Melanie E.
De lay, Michael D.
Johnson, Amy J.
Guster, Sara E.
Freitas, Michael A.
Parthun, Mark R.
Wang, Dasheng
Kulp, Samuel K.
Grever, Michael R.
Chen, Ching-Shih
Byrd, John C.
BLOOD, 2006, 108 (11) : 794A - 795A
[33] Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity
Loeuillet, C.
Touquet, B.
Oury, B.
Eddaikra, N.
Pons, J. L.
Guichou, J. F.
Labesse, G.
Sereno, D.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2018, 8 (01): : 59 - 66
[34] Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand
Nishino, N
Yoshikawa, D
Watanabe, LA
Kato, T
Jose, B
Komatsu, Y
Sumida, Y
Yoshida, M
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) : 2427 - 2431
[35] Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors
Zhu, Fugui
Meng, Xiangguo
Liang, Huixin
Sheng, Chunquan
Dong, Guoqiang
Liu, Dan
Wu, Shanchao
BIOORGANIC CHEMISTRY, 2022, 122
[36] Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo
Fischle, W
Dequiedt, F
Fillion, M
Hendzel, MJ
Voelter, W
Verdin, E
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 35826 - 35835
[37] Synthesis and cancer antiproliferative activity of new histone deacetylase inhibitors: hydrophilic hydroxamates and 2-aminobenzamide-containing derivatives
Nagaoka, Y.
Maeda, T.
Kawai, Y.
Nakashima, D.
Oikawa, T.
Shimoke, K.
Ikeuchi, T.
Kuwajima, H.
Uesato, S.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (06) : 697 - 708
[38] Design of Piperazine Organoiron Macromolecules with Antibacterial and Anticancer Activity
Abd-El-Aziz, Alaa S.
Abdelghani, Amani A.
Pearson, Jason K.
Awad, Mohamed K.
Overy, David P.
Kerr, Russell G.
MACROMOLECULAR CHEMISTRY AND PHYSICS, 2016, 217 (08) : 987 - 996
[39] Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors
Terracciano, Stefania
Chini, Maria Giovanna
Riccio, Raffaele
Bruno, Ines
Bifulco, Giuseppe
CHEMMEDCHEM, 2012, 7 (04) : 694 - 702
[40] Synthesis, characterization and anticancer activity of piperazine substituted porphyrins
Li, HP
Guo, CC
Ruan, JM
Huang, BY
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2004, 24 (07) : 783 - 787

← 1 2 3 4 5 →